Cancer Genetics, Inc. to Showcase Research on Its Novel, Patent-Protected, Kidney Cancer Diagnostic Array at the Association for Molecular Pathology 2013 Annual Conference

RUTHERFORD, N.J., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or the “Company”), a DNA-based diagnostics company focused on developing genomic-based oncology tests and services, announced today that it will present data from a six-month research collaboration with the Memorial Sloan-Kettering Cancer Center, at the Association for Molecular Pathology (AMP) 2013 Annual Conference.

Help employers find you! Check out all the jobs and post your resume.